Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Down 5.2% - Time to Sell?
Calumet Specialty Products Partners (NASDAQ:CLMT) shares fell 5.2% to $12.69, with trading volume down 40% from average. Analysts have mixed ratings: UBS upgraded to "neutral" with a price target of $12, while Wells Fargo set a target of $28. The stock has a consensus rating of "Hold" and a price target of $20.80. The company reported a quarterly EPS of ($0.47), exceeding estimates, but revenue declined 2.8% year-over-year. CFO David Lunin purchased 2,500 shares at $13.05 each, increasing insider ownership to 2.91%.
Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) fell 5.2% on Friday . The company traded as low as $12.63 and last traded at $12.69. 412,451 shares traded hands during trading, a decline of 40% from the average session volume of 684,999 shares. The stock had previously closed at $13.38.
Wall Street Analyst Weigh In
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
A number of research firms recently weighed in on CLMT. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and reduced their price objective for the company from $15.00 to $12.00 in a research report on Monday. Wells Fargo & Company reduced their price objective on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. TD Cowen lowered Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their price objective for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. Finally, HC Wainwright reaffirmed a "buy" rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a research report on Monday, March 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $20.80.
Check Out Our Latest Report on CLMT
Calumet Specialty Products Partners Trading Down 4.5 %
The stock has a market capitalization of $1.10 billion, a PE ratio of -4.62 and a beta of 1.88. The stock has a 50 day moving average price of $15.55 and a 200-day moving average price of $18.65.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.59. The firm had revenue of $949.50 million during the quarter, compared to analysts' expectations of $921.76 million. The business's quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.59) earnings per share. Research analysts forecast that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current year.
Insider Transactions at Calumet Specialty Products Partners
In related news, CFO David Lunin bought 2,500 shares of the stock in a transaction that occurred on Tuesday, March 4th. The shares were bought at an average cost of $13.05 per share, for a total transaction of $32,625.00. Following the completion of the transaction, the chief financial officer now owns 2,500 shares of the company's stock, valued at approximately $32,625. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.91% of the company's stock.
Calumet Specialty Products Partners Company Profile
(Get Free Report)Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Further Reading
- Five stocks we like better than Calumet Specialty Products Partners
- Why Invest in 5G? How to Invest in 5G Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- With Risk Tolerance, One Size Does Not Fit All
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What is the Dow Jones Industrial Average (DJIA)?
- Micron Stock Will Retest All-Time Highs This Year
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
